Skip to main content

Abstract

Obesity is a major public health concern in the United States and is related to a considerable number of chronic diseases including hypertension, type 2 diabetes, stroke, heart disease, degenerative joint disease, and several types of cancer. Because of the medical implications and health-care costs associated with obesity, as well as the negative social and psychological impacts, many individuals turn to nonprescription nutritional weight loss supplements hoping for a quick fix, and the weight loss industry has responded by offering a variety of products that generates billions of dollars each year in sales.

Most nutritional weight loss supplements are purported to work by increasing energy expenditure, modulating carbohydrate or fat metabolism, increasing satiety, or blocking fat or carbohydrate absorption. To review the literally hundreds of nutritional weight loss supplements available on the market today is well beyond the scope of this chapter. Therefore, several of the most commonly used supplements were selected for critical review, and practical recommendations are provided based upon the findings of well-controlled, randomized clinical trials that examined their efficacy.

In the majority of cases, the nutritional supplements reviewed either elicited no clinically meaningful effect (i.e., ≥5 % change in body weight) or resulted in changes in body weight and composition that are similar to that which occurs through a restricted diet and exercise program. There is evidence to suggest that herbal forms of ephedrine, such as ma huang, combined with caffeine or caffeine and aspirin (i.e., ECA stack) are effective for inducing moderate weight loss in overweight adults. However, because of the ban on ephedra, it is not practical to recommend it for weight loss, and ephedra-free supplements, such as bitter orange, do not appear to be as effective. Green bean coffee extract, capsaicinoids, and white kidney bean extract (Phaseolus vulgaris) do appear to hold some promise as possible adjuvant treatments for weight loss; however, most dietary weight loss supplements used alone or in combination are largely ineffective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2009;316:104–8.

    Article  PubMed  CAS  Google Scholar 

  2. Radimer KL, Subar AF, Thompson FE. Nonvitamin, nonmineral dietary supplements: issues and findings from NHANES III. J Am Diet Assoc. 2000;100:447–54.

    Article  CAS  PubMed  Google Scholar 

  3. Marketdata Enterprises, Inc. Weight loss market sheds some dollars in 2013 (Press Release, 4 Feb 2014).

    Google Scholar 

  4. Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen C, Solomon JL. An herbal supplement containing ma huang-guarana for weight loss: a randomized, double-blind trial. Int J Obes. 2001;25:316–24.

    Article  CAS  Google Scholar 

  5. Greenway FL. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes Rev. 2001;2:199–211.

    Article  CAS  PubMed  Google Scholar 

  6. Young R, Glennon RA. Discriminative stimulus properties of (-) ephedrine. Pharmacol Biochem Behav. 1998;60(3):771–5.

    Article  CAS  PubMed  Google Scholar 

  7. Blumenthal M. Bitter orange peel and synephrine: Part 1. HerbalGram 2005;66: American Botanical Council. http://cms.herbalgram.org/herbalgram/issue66/article2833.html. Accessed 26 May 2014.

  8. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes RL, Jungvig L, Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289:1537–45.

    CAS  PubMed  Google Scholar 

  9. Allison DB, Fontaine KR, Heshka S, Mentore JL, Heymsfield SB. Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr. 2001;41(1):1–28.

    Article  CAS  PubMed  Google Scholar 

  10. Kovacs EMR, Mela DJ. Metabolically active functional food ingredients for weight control. Obes Rev. 2006;7:59–78.

    Article  CAS  PubMed  Google Scholar 

  11. FDA Consumer Health Information. Warning on Hydroxycut Products. 1 May 2009. www.fda.gov/consumer/updates/hydroxycut050109.html

  12. Hutchins GM. Dietary supplements containing ephedra alkaloids. N Engl J Med. 2001;344(14):1095–7.

    Article  CAS  PubMed  Google Scholar 

  13. Dulloo AG. Herbal stimulation of ephedrine and caffeine in the treatment of obesity. Int J Obes. 2002;26:590–2.

    Article  CAS  Google Scholar 

  14. Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes. 2002;26:593–604.

    Article  CAS  Google Scholar 

  15. Kalman CM, Minsch A. Ephedrine, caffeine, and aspirin enhance fat loss under nonexercising conditions. J Am Coll Nutr. 1997;16 Suppl 2:S149. Abs.

    Google Scholar 

  16. Daly PA, Krieger DR, Dulloo AG, Young JB, Landsberg L. Ephedrine, caffeine, and aspirin: safety and efficacy for treatment of obesity. Int J Obes. 1993;17(Suppl1):S73–8.

    Google Scholar 

  17. Liu AG, Smith SR, Fujioka K, Greenway FL. The effect of leptin, caffeine/ephedrine and their combination upon visceral fat mass and weight loss. Obesity. 2013;21:1991–6.

    Article  CAS  PubMed  Google Scholar 

  18. Vukovich MD, Schoorman R, Heilman C, Jacob P, Benowitz NL. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate, and blood pressure. Clin Exp Pharmacol Physiol. 2005;32(1-2):47–53.

    Article  PubMed  Google Scholar 

  19. Fugh-Berman A, Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med. 2004;229:698–704.

    CAS  Google Scholar 

  20. Bent S, Padula A, Neuhaus J. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol. 2004;94:1359–61.

    Article  PubMed  Google Scholar 

  21. Penzak SR, Jann MW, Cold JA, Hon YY, Desai HD, Gurley BJ. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. J Clin Pharmacol. 2001;41:1059–63.

    Article  CAS  PubMed  Google Scholar 

  22. Allison DB, Cutter G, Poehman ET, Moore DR, Barnes S. Exactly which synephrine alkaloids does citrus aurantium (bitter orange) contain? Int J Obes (Lond). 2005;29:443–6.

    Article  CAS  Google Scholar 

  23. Carpene C, Galitzky J, Fontana E, Atgie C, Lafontan M, Berlan M. Selective activation of beta3-adrenoreceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch Pharmacol. 1999;359(4):310–21.

    Article  CAS  PubMed  Google Scholar 

  24. Colker CM, Kalman DS, Torina GC, Perlis T, Street C. Effects of Citrus aurantium, caffeine, and St. John’s Wort on body fat loss, lipid levels, and mood states, in overweight healthy adults. Curr Ther Res. 1999;60(3):145–52.

    Article  Google Scholar 

  25. Heyward VH, Stolarczyk LM. Applied body composition assessment. Champaign, IL: Human Kinetics; 1996. p. 47–54.

    Google Scholar 

  26. Armstrong WJ, Johnson P, Duhme S. The effect of commercial thermogenic weight loss supplement on body composition and energy expenditure in obese adults. J Exer Physiol Online. 2001;4(2):28–35.

    Google Scholar 

  27. Sale C, Harris RC, Delves S, Corbett J. Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males. Int J Obes. 2006;30:764–73.

    Article  CAS  Google Scholar 

  28. Zenk JL, Liekam SA, Kassen LJ, Kuskowski MA. Effect of Lean System 7 on metabolic rate and body composition. Nutrition. 2005;21:179–85.

    Article  PubMed  Google Scholar 

  29. Lopez HL, Ziegenfuss TN, Hofheins JE, Habowski SM, Arent SM, Weir JP, Ferrando AA. Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women. J Int Soc Sport Nutr. 2013;10:22.

    Article  CAS  Google Scholar 

  30. Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006;7:79–88.

    Article  CAS  PubMed  Google Scholar 

  31. Wang H, Wen Y, Du Y, et al. Effect of catechin enriched green tea on body composition. Obesity. 2010;18(4):773–9.

    Article  PubMed  CAS  Google Scholar 

  32. Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes. 2009;33:956–61.

    Article  CAS  Google Scholar 

  33. Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr. 2010;91:73–81.

    Article  CAS  PubMed  Google Scholar 

  34. Hursel R, Westerterp-Plantenga MS. Thermogenic ingredients and body weight regulation. Int J Obes. 2010;34:659–69.

    Article  CAS  Google Scholar 

  35. Manore MM. Dietary supplements for improving body composition and reducing body weight: where is the evidence? Int J Sport Nutr Exerc Metab. 2012;22:139–54.

    CAS  PubMed  Google Scholar 

  36. Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr. 2006;83:674–80.

    CAS  PubMed  Google Scholar 

  37. Galgani JE, Ravussin E. Effect of dihydrocapsiate on resting metabolic rate in humans. Am J Clin Nutr. 2010;92:1089–93.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Whiting S, Derbyshire E, Tiwari BK. Capsaicinoids and capsinoids. A potential for weight management? A systematic review of the evidence. Appetite. 2012;59:341–8.

    Article  CAS  PubMed  Google Scholar 

  39. Luo XJ, Peng J, Li YJ. Recent advances in the study of capsaicinoids and capsinoids. Eur J Pharmacol. 2011;650:1–7.

    Article  CAS  PubMed  Google Scholar 

  40. Clegg ME, Golsorkhi M, Henry CJ. Combined medium-chain triglyceride and chili feeding increases diet-induced thermogenesis in normal-weight humans. Eur J Nutr. 2013;52:1579–85.

    Article  CAS  PubMed  Google Scholar 

  41. Stanko RT, Mendelow H, Shinozuka H, Adibi SA. Prevention of alcohol-induced fatty liver by natural metabolites and riboflavin. J Lab Clin Med. 1978;91:228–35.

    CAS  PubMed  Google Scholar 

  42. Stanko RT. Methods for preventing body fat deposition in mammals. US Patent No. 4,812,479; 14 Mar 1989.

    Google Scholar 

  43. Stanko RT, Adibi SA. Inhibition of lipid accumulation and enhancement of energy expenditure by the addition of pyruvate and dihydroxyacetone to a rat diet. Metabolism. 1986;35:182–6.

    Article  CAS  PubMed  Google Scholar 

  44. Stanko RT, Arch JE. Inhibition of regain in body weight and fat wit addition of 3-carbon compounds to the diet with hyperenergetic refeeding after weight reduction. Int J Obes Relat Metab Disord. 1996;20:925–30.

    CAS  PubMed  Google Scholar 

  45. Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate. Am J Clin Nutr. 1992;55:771–6.

    CAS  PubMed  Google Scholar 

  46. Stanko RT, Reynolds HR, Hoyson R, Jonosky JE, Wolf R. Pyruvate supplementation on a low cholesterol, low fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients. Am J Clin Nutr. 1994;59:423–7.

    CAS  PubMed  Google Scholar 

  47. Stanko RT, Ferguson TL, Newman CW, Newman RK. Reduction of carcass fat in swine with dietary addition of dihydroxyacetone and pyruvate. J Anim Sci. 1989;67:1272–8.

    CAS  PubMed  Google Scholar 

  48. Kalman D, Colker CM, Stark R, Minsch A, Wilets I, Antonio J. Effect of pyruvate supplementation on body composition and mood. Curr Ther Res. 1998;59(11):793–802.

    Article  CAS  Google Scholar 

  49. Gunther CW, Legowski AP, Lyle RM, McCabe GP, Eagan MS, Peacock M, Teegarden D. Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. Am J Clin Nutr. 2005;81:751–6.

    CAS  PubMed  Google Scholar 

  50. Kalman D, Colker CM, Welets I, Roufs JB, Antonio J. The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition. 1999;15(5):337–40.

    Article  CAS  PubMed  Google Scholar 

  51. Koh-Banerjee PK, Ferreira MP, Greenwood M, Bowden RG, Cowan PN, Almada AL, Kreider RB. Effects of calcium pyruvate supplementation during training on body composition, exercise capacity, and metabolic responses to exercise. Nutrition. 2005;21(3):312–9.

    Article  CAS  PubMed  Google Scholar 

  52. Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr. 1999;9:146–65.

    CAS  PubMed  Google Scholar 

  53. Onakpoya I, Hunt K, Wider B, Ernst E. Pyruvate supplementation for weight loss: a systematic review and meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr. 2014;54:17–23.

    Article  CAS  PubMed  Google Scholar 

  54. Onakpoya I, Rohini T, Ernst E. The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomized clinical trials. Gastroenterol Res Pract. 2011;2011:6. Article ID 382852.

    Article  Google Scholar 

  55. Quick M, Kiefer D. Weighing in: green coffee bean extract – a potential safe and effective weight loss supplement? Integr Med Alert;1 Sept 2013.

    Google Scholar 

  56. Flanagan J, Bily A, Rolland Y, Roller M. Lipolytic activity of Svetol, a decaffeinated green coffee bean extract. Phytother Res. 2014;28:946–8.

    Article  CAS  PubMed  Google Scholar 

  57. Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006;6:9.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Cho AS, Jeon SM, Kim MJ, et al. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol. 2010;48:937–43.

    Article  CAS  PubMed  Google Scholar 

  59. Thom E. The effect of chlorogenic acid enriched coffee on glucose absorption in health volunteers and its effect on body mass when used long-term in overweight and obese people. J Int Med Res. 2007;35:900–8.

    Article  CAS  PubMed  Google Scholar 

  60. Vinson JA, Burnham BR, Nagendran MV. Randomized, double-blind, placebo controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes. 2012;5:21–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Lukaski HC, Siders WA, Penland JG. Chromium picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition. 2007;23:187–95.

    Article  CAS  PubMed  Google Scholar 

  62. Pittler MH, Stevinson C, Ernst E. Chromium picolinate for body weight reduction: meta-analysis of randomized trials. Int J Obes. 2003;27(4):522–9.

    Article  CAS  Google Scholar 

  63. Yazaki Y, Faridi Z, Ma Y, Ali A, Northrup V, Njike VY, Liberti L, Katz DL. A pilot study of chromium picolinate for weight loss. J Altern Complement Med. 2010;16(3):29–299.

    Article  Google Scholar 

  64. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr. 2004;79:529–36.

    CAS  PubMed  Google Scholar 

  65. Han LK, Kimura Y, Okuda H. Reduction in fat storage during chitin-chitosan treatment in mice fed a high fat diet. Int J Obes. 1999;23:174–9.

    Article  CAS  Google Scholar 

  66. Trautwein EA, Jurgensen U, Erbersdobler HF. Cholesterol-lowering and gallstone-preventing action of chitosans with different degrees of deacetylation in hamsters fed cholesterol rich-diets. Nutr Res. 1997;17:1053–65.

    Article  CAS  Google Scholar 

  67. Jull AB, Mhurchu N, Bennett DA, Dunshea-Mooij CA, Rodgers A. Chitosan for overweight or obesity. Cochrane Database Syst Rev. 2008;3, CD003892.

    PubMed  Google Scholar 

  68. Saper RB, Eisenberg DM, Phillips RS. Common dietary supplements for weight loss. Am Fam Physician. 2004;70:1731–8.

    PubMed  Google Scholar 

  69. Gades MD, Stern JS. Chitosan supplementation and fecal fat excretion in men. Obes Res. 2003;11:683–8.

    Article  CAS  PubMed  Google Scholar 

  70. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (HCA) as a potential anti-obesity agent. JAMA. 1998;280(18):1596–600.

    Article  CAS  PubMed  Google Scholar 

  71. Kovacs EMR, Westerterp-Plantega MS, Saris WHM. The effects of 2-week ingestion of (-)-hydroxycitrate and (-)-hydroxycitrate combined with medium-chain triglycerides on satiety, fat oxidation, energy expenditure and body weight. Int J Obes. 2001;25:1087–94.

    Article  CAS  Google Scholar 

  72. Westerterp-Plantenga MS, Kovacs EMR. The effect of (-)-hydroxycitrate on energy intake and satiety in overweight humans. Int J Obes. 2002;26:870–2.

    Article  CAS  Google Scholar 

  73. Kriketos AD, Thomson HR, Greene H, Hill JO. (-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state. Int J Obes. 1999;23:867–73.

    Article  CAS  Google Scholar 

  74. Van Loon LJC, van Rooijen JJM, Niesen B, Verhagen H, Saris WHM, Wagenmakers AJM. Effects of acute (-)-hydroxycitrate supplementation on substrate metabolism at rest and during exercise in humans. Am J Clin Nutr. 2000;72:1445–50.

    PubMed  Google Scholar 

  75. Marquez F, Babio N, Bullo M, Salas-Salvado J. Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans. Crit Rev Food Sci Nutr. 2012;52:585–94.

    Article  PubMed  Google Scholar 

  76. Malpuech-Brugere C, Wihelmine PHG, de Verboeket-van V, Mensink RP, et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res. 2004;12(4):591–8.

    Article  CAS  PubMed  Google Scholar 

  77. Tricon S, Yaqoob P. Conjugated linoleic acid and human health: a critical evaluation of the evidence. Curr Opin Clin Nutr Metab Care. 2006;9(2):105–10.

    Article  CAS  PubMed  Google Scholar 

  78. Meinert Larsen T, Toubro S, Gudmundsen O, Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr. 2006;83:606–12.

    Google Scholar 

  79. Brown JM, McIntosh MK. Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity. J Nutr. 2003;133(10):3041–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  80. Tricon S, Burdge GC, Kew S, Banerjee T, et al. Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr. 2004;80:614–20.

    CAS  PubMed  Google Scholar 

  81. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. 2004;79:1118–25.

    CAS  PubMed  Google Scholar 

  82. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomized controlled trial. Int J Obes. 2001;25:1129–35.

    Article  CAS  Google Scholar 

  83. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res. 2003;44(12):2234–41.

    Article  CAS  PubMed  Google Scholar 

  84. Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007;85(5):1203–11.

    CAS  PubMed  Google Scholar 

  85. Onakpoya I, Posadzki PP, Watson LK, Davies LA, Ernst E. The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials. Eur J Nutr. 2012;51:127–34.

    Article  CAS  PubMed  Google Scholar 

  86. Metz JA, Karanja N, Torok J, McCaron DA. Modification of total body fat in spontaneously hypertensive rats and Wistar-Kyoto rats by dietary calcium and sodium. Am J Hypertens. 1988;1:58–60.

    CAS  PubMed  Google Scholar 

  87. Bursey RG, Sharkey T, Miller GD. High calcium intake lowers weight in lean and fatty Zucker rats. FASEB J. 1989;3137:A265. Abs.

    Google Scholar 

  88. Teegarden D, Lin YC, Weaver CM, Lyle RM, McCabe GP. Calcium intake related to change in body weight in young women. FASEB J. 1999;13:A873. Abs.

    Google Scholar 

  89. Zemel MB, Shi H, Zemel PC, DiRienzo D. Calcium and calcium-rich dairy products reduce body fat. FASEB J. 1999;12:LB211. abs.

    Google Scholar 

  90. Zemel MB, Shi H, Greer B, DiRienzo D, Zemel P. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132–8.

    CAS  PubMed  Google Scholar 

  91. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MH, Rafferty K, Hinders S. Calcium intake and body weight. J Clin Endocrinol Metab. 2000;85:4635–8.

    CAS  PubMed  Google Scholar 

  92. Shapses SA, Stanley H, Heymsfield SB. Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab. 2004;89(2):632–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  93. Barr SI, McCarron DA, Heaney RP, Dawson-Hughes B, Berga SL, Stern J, Oparil S. Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc. 2000;100:810–7.

    Article  CAS  PubMed  Google Scholar 

  94. DeJongh ED, Binkley TL, Specker BL. Fat mass gain is lower in calcium-supplemented than in unsupplemented preschool children with low dietary calcium intakes. Am J Clin Nutr. 2006;84(5):1123–7.

    PubMed Central  CAS  PubMed  Google Scholar 

  95. Haub MD, Simons TR, Cook CM, Remig VM, Al-Tamimi EK, Holcomb CA. Calcium-fortified beverage supplementation on body composition in postmenopausal women. Nutr J. 2005;4:21 (PubMed online).

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  96. Zemel MB, Thompson W, Milstead A, Morris K, Campbell P. Calcium and dietary acceleration of weight and fat loss during energy restriction in obese adults. Obes Res. 2004;12:582–90.

    Article  CAS  PubMed  Google Scholar 

  97. Zemel MB, et al. Materials and methods for the treatment or prevention of obesity. US Patent No. 6,384,087; 7 May 2002.

    Google Scholar 

  98. Lanou AJ, Barnard ND. Dairy and weight loss hypothesis: an evaluation of the clinical trials. Nutr Rev. 2008;66(5):272–9.

    Article  PubMed  Google Scholar 

  99. Onakpoya I, Perry R, Zhang J, Ernst E. Efficacy of calcium supplementation for management of overweight and obesity: systematic review of randomized clinical trials. Nutr Rev. 2011;69(6):335–43.

    Article  PubMed  Google Scholar 

  100. Trowman R, Dumville JC, Hahn S, Torgerson DJ. A systematic review of the effects of calcium supplementation on body weight. Br J Nutr. 2006;95:1033–8.

    Article  CAS  PubMed  Google Scholar 

  101. Vinson JA, Kharrat HA, Shuta D. Investigation of an amylase inhibitor on human glucose absorption after starch consumption. Open Nutraceuticals J. 2009;2:88–91.

    Article  CAS  Google Scholar 

  102. Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011;10:24.

    Article  PubMed Central  PubMed  Google Scholar 

  103. Rothacker D. Reduction in body weight with a starch blocking diet aid: StarchAway comparison with placebo. Leiner Health Products 2003; http://www.phase2info.com/pdf/Phase2_Study6.pdf (online source).

  104. Celleno L, Tolaini MV, D’Amore A, Perricone NV, Preuss HG. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition in overweight men and women. Int J Med Sci. 2007;4(1):45–53.

    Article  PubMed Central  PubMed  Google Scholar 

  105. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes. 1984;8(4):289–93.

    CAS  PubMed  Google Scholar 

  106. Keithly J, Swanson B. Glucomannan and obesity: a critical review. Altern Ther Health Med. 2005;11(6):30–4.

    Google Scholar 

  107. Keithly JK, Swanson B, Mikolaitis SL, DeMeo M, Zeller JM, Fogg L, Adamji J. Safety and efficacy of glucomannan for weight loss in overweight and moderately obese adults. J Obes. 2013;2013:7. 610908.

    Google Scholar 

  108. Lyon M, Wood S, Pelletier X, Donazzolo Y, Gahler R, Bellisle F. Effect of a 3-month supplementation with a novel soluble highly viscous polysaccharide on anthropometry and blood lipids in nondieting overweight or obese adults. J Hum Nutr Diet. 2011;24:351–9.

    Article  CAS  PubMed  Google Scholar 

  109. Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2014;33(1):77–8.

    Article  CAS  Google Scholar 

  110. Pittler MH, Ernst E. Guar gum for body weight reduction: Meta-analysis of randomized trials. Am J Med. 2001;110:724–30.

    Article  CAS  PubMed  Google Scholar 

  111. Birketvedt GS, Shimshi M, Erling T, Florholmen J. Experiences with three different fiber supplements in weight reduction. Med Sci Monit. 2005;11(1):I5–8.

    Google Scholar 

  112. Anderson JW, Baird P, Davis R, et al. Health benefits of dietary fiber. Nutr Rev. 2009;67(4):188–205.

    Article  PubMed  Google Scholar 

  113. Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: a systematic review. Obes Rev. 2005;6(2):93–111.

    Article  CAS  PubMed  Google Scholar 

  114. Stevens J, Truesdale KP, McClain JE, Cai J. The definition of weight management. Int J Obes. 2006;30:391–9.

    Article  CAS  Google Scholar 

  115. Cowburn G, Hillsdon M, Hankey CR. Obesity management by life-style strategies. Br Med Bull. 1997;53:389–408.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joan M. Eckerson PhD, CSCS, FACSM, FNSCA .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Eckerson, J.M. (2015). Weight Loss Nutritional Supplements. In: Greenwood, M., Cooke, M., Ziegenfuss, T., Kalman, D., Antonio, J. (eds) Nutritional Supplements in Sports and Exercise. Springer, Cham. https://doi.org/10.1007/978-3-319-18230-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18230-8_8

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18229-2

  • Online ISBN: 978-3-319-18230-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics